The c-MET-JAK1/2-STAT3 signalling axis is regulated by ADAM17 and is a key mediator of resistance to MEK inhibition in KRAS mutant colorectal cancer

Van Schaeybroeck, S. (Keynote speaker)

Activity: Talk or presentation typesInvited talk

PeriodNov 2013
Held atNational Cancer Research Institute, United Kingdom
Degree of RecognitionInternational